結核（TB）は、結核菌によって引き起こされる感染症です。これらの細菌は一般的に人間の肺に感染します。しかし、それは他の体の部分/臓器にも感染する可能性があります。結核には、潜伏性、活動性、薬剤耐性の3つの主要なタイプがあります。潜在性結核症の場合、不活性型の細菌が存在するため、症状を特定することはできません。活動性結核では、症状がはっきりと見え、人から人へと広がる可能性があります。 2週間以上の咳、胸痛、喀血、悪寒、倦怠感、意図しない体重減少、発熱、食欲不振は、活動性結核の一般的な症状の一部です。 HIV / AIDS、重度の腎臓病、癌、糖尿病、栄養失調は、結核に関連することが一般的に見られる主要な危険因子の一部です。
多剤耐性結核の有病率の高まりは、結核薬市場を牽引しています。薬物不足は、特に世界の低中所得国において、結核薬市場の主要な制約となっています。 HIV / AIDSなどの病気や肥満などの状態に関連する結核は管理が非常に困難です。結核薬市場は、薬のクラス、病気の種類、エンドユーザー、および地域に基づいて分割できます。医薬品クラスの観点から、市場は一次治療、二次治療、および併用療法に分類することができます。イソニアジド、ピラジナミド、リファンピン、およびエタンブトールは、主に結核の第一選択療法を構成します。一方、ストレプトマイシン、カプレオマイシン、エチオナミド、レボフロキサシン、およびガチフロキサシンは、一般的に二次治療の一部と見なされます。二次治療は、結核薬市場の急速に成長しているセグメントになると予想されます。
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Tuberculosis Drug Market Size Growth Rate by Type (2020-2025)
1.3.2 First-line Anti-TB Drugs
1.3.3 Second-line Anti-TB Drugs
1.4 Market Segment by Application
1.4.1 Global Tuberculosis Drug Market Share by Application (2020-2025)
1.4.2 Active TB
1.4.3 Latent TB
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Tuberculosis Drug Market Size
2.1.1 Global Tuberculosis Drug Revenue 2015-2025
2.1.2 Global Tuberculosis Drug Sales 2015-2025
2.2 Tuberculosis Drug Growth Rate by Regions
2.2.1 Global Tuberculosis Drug Sales by Regions 2015-2019
2.2.2 Global Tuberculosis Drug Revenue by Regions 2015-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Tuberculosis Drug Sales by Manufacturers
3.1.1 Tuberculosis Drug Sales by Manufacturers 2015-2019
3.1.2 Tuberculosis Drug Sales Market Share by Manufacturers 2015-2019
3.2 Revenue by Manufacturers
3.2.1 Tuberculosis Drug Revenue by Manufacturers (2015-2019)
3.2.2 Tuberculosis Drug Revenue Share by Manufacturers (2015-2019)
3.2.3 Global Tuberculosis Drug Market Concentration Ratio (CR5 and HHI)
3.3 Tuberculosis Drug Price by Manufacturers
3.4 Key Manufacturers Tuberculosis Drug Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Tuberculosis Drug Market
3.6 Key Manufacturers Tuberculosis Drug Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 First-line Anti-TB Drugs Sales and Revenue (2015-2019)
4.1.2 Second-line Anti-TB Drugs Sales and Revenue (2015-2019)
4.2 Global Tuberculosis Drug Sales Market Share by Type
4.3 Global Tuberculosis Drug Revenue Market Share by Type
4.4 Tuberculosis Drug Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Tuberculosis Drug Sales by Application
6 United States
6.1 United States Tuberculosis Drug Breakdown Data by Company
6.2 United States Tuberculosis Drug Breakdown Data by Type
6.3 United States Tuberculosis Drug Breakdown Data by Application
7 European Union
7.1 European Union Tuberculosis Drug Breakdown Data by Company
7.2 European Union Tuberculosis Drug Breakdown Data by Type
7.3 European Union Tuberculosis Drug Breakdown Data by Application
8 China
8.1 China Tuberculosis Drug Breakdown Data by Company
8.2 China Tuberculosis Drug Breakdown Data by Type
8.3 China Tuberculosis Drug Breakdown Data by Application
9 Rest of World
9.1 Rest of World Tuberculosis Drug Breakdown Data by Company
9.2 Rest of World Tuberculosis Drug Breakdown Data by Type
9.3 Rest of World Tuberculosis Drug Breakdown Data by Application
9.4 Rest of World Tuberculosis Drug Breakdown Data by Countries
9.4.1 Rest of World Tuberculosis Drug Sales by Countries
9.4.2 Rest of World Tuberculosis Drug Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Lupin
10.1.1 Lupin Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Tuberculosis Drug
10.1.4 Tuberculosis Drug Product Introduction
10.1.5 Lupin Recent Development
10.2 Otsuka Novel Products
10.2.1 Otsuka Novel Products Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Tuberculosis Drug
10.2.4 Tuberculosis Drug Product Introduction
10.2.5 Otsuka Novel Products Recent Development
10.3 Pfizer
10.3.1 Pfizer Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Tuberculosis Drug
10.3.4 Tuberculosis Drug Product Introduction
10.3.5 Pfizer Recent Development
10.4 Sanofi
10.4.1 Sanofi Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Tuberculosis Drug
10.4.4 Tuberculosis Drug Product Introduction
10.4.5 Sanofi Recent Development
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Tuberculosis Drug Sales Channels
11.2.2 Tuberculosis Drug Distributors
11.3 Tuberculosis Drug Customers
12 Market Forecast
12.1 Global Tuberculosis Drug Sales and Revenue Forecast 2020-2025
12.2 Global Tuberculosis Drug Sales Forecast by Type
12.3 Global Tuberculosis Drug Sales Forecast by Application
12.4 Tuberculosis Drug Forecast by Regions
12.4.1 Global Tuberculosis Drug Sales Forecast by Regions 2020-2025
12.4.2 Global Tuberculosis Drug Revenue Forecast by Regions 2020-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
